Quick Take #4: Sept 25 Updates! Part Deux: Benefits of Drug Treatment of ADHD, ChatGPT-induced Bromide Poisoning Psychosis, Ineffectiveness of Gabapentin, Newest GLP-1 Trial Results, and MORE!!!

Welcome back to part two of my September edition of my psychiatry quick takes episode series. It's been a busy couple months in the news, so I have several more tidbits for September. Today I'm going to talk about a new study on long-term medication treatment of ADHD, psychosis caused by bromide poisoning after consulting ChatGPT, more information about kanna, another study showing that gabapentin just doesn't work that well, a new formulation of lecanemab for Alzheimer's which is easier to take, the latest trial results on the next likely GLP-1, oral orforglipron for weight loss, a fascinating case of a woman who had a fecal microbiota transplant and ceased to have symptoms of bipolar disorder, a new wearable lithium sensor to be hitting the market, and a new synthetic opioid that's 50 times stronger than kratom to be on the look out for. Please have a listen!